Last quarter (Q0 0), Manzo Pharmaceuticals's total revenue was $―, a decrease of ― from previous quarter. In Q0, Manzo Pharmaceuticals's net income was $-1.23M. See Manzo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 04
Dec 03
Total Revenue
$ ―
$ ―
Gross Profit
$ 20.97K
$ 755.89K
Operating Expenses
$ ―
$ ―
Depreciation and Amortization
$ ―
$ ―
EBITDA
$ -2.85M
$ -2.30M
Operating Income
$ -3.20M
$ -3.25M
Other Income/Expenses
$ ―
$ ―
Pretax Income
$ ―
$ ―
Net Income
$ -4.15M
$ -3.95M
Per Share Metrics
$ ―
$ ―
Basic EPS
$ ―
$ ―
Diluted EPS
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
Currency in USD
Manzo Pharmaceuticals Earnings and Revenue History